Jared Holz, Mizuho Healthcare Sector strategist, joins 'Closing Bell Overtime' to talk Moderna and Novo Nordisk.

Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...

Hence, researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

Shares of Moderna, Inc. plunged over 20% on Monday to their lowest levels since mid-April 2020 and were on course to mark ...

What happened to the need to end commuting and presenteeism? Or to our gratitude for healthcare workers or our resolution to ...

And regular polling carried out by YouGov suggests adults are increasingly likely to say that vaccines have harmful side ...

Separately, the UK government purchased 60 million doses of Moderna’s COVID-19 vaccine, which may include an updated booster vaccine candidate against the newer variants like Omicron if ...

The two companies have submitted data from a phase 1 trial in support of the booster dose to the US regulator ... of either the Pfizer/BioNTech or Moderna COVID-19 vaccines for people with ...

Five years after the COVID-19 pandemic hit South Carolina and the U.S., it is still changing health care, from wastewater ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...